EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 PROMISSORY NOTE $5,307,096.94 May 12, 2026 FOR VALUE RECEIVED, Foxo Technologies Inc., a Delaware corporation (the “ Maker ”) promises to pay to the order of Sabby Volatility Warrant Master Fund, Ltd., or its registered assigns (the “ Payee ”), upon the terms set forth below, the principal sum of Five Million Three Hundred and Seven Thousand, and Ninety Six Dollars and Ninety Four Cents ($5,307,096.94). (This Promissory Note, the “ Note ”). 1. Payments. (a) The principal under this Note shall be due on the earlier of: (i) May 12, 2027; or (ii) the occurrence of an Event of Default (as defined below, in each case unless due earlier in accordance with the terms of this Note 2. Unsecured Obligation. This Note is an unsecured obligation of the Company provided however the Company shall not incur any other indebtedness which is senior in preference to the Note while the Note is outstanding and provided however that repayment is made upon completion of a public offering or up-listing to a recognized stock exchange. 3. Events of Default. (a) “ Event of Default ”, wherever used herein, means any one of the following events (whatever …
Open exhibit ↗Current Report · Items 1.01, 9.01 · 8-K
FOXO TECHNOLOGIES INC.
FOXOOTCEQUITYCurrent
Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On May 12, 2026, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), entered into two Exchange Agreements (each, an “ Exchange Agreement ” and collectively, the “ Exchange Agreements ”), each dated as of May 12, 2026, by and between the Company and each of (i) an institutional investor (“ Investor 1 ”) and (ii) a second institutio…
Company context
We are a healthcare services and technology company operating in three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs, formerly referred to as Labs and Life. These segments further operate in four synergistic divisions, a rural hospital division and a mental and behavioral health division, which make up our Healthcare segment, a biospecimens division, which makes up our Life Science Services segment and an epigenetics diagnostics and interpretation division, which makes up our Labs segment. Our rural hospital division, biospecimens division and epigenetics diagnostics and interpretation division operate through wholly owned subsidiaries, and our behavioral health division operates through a majority-owned subsidiary.
Current securities
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Filed exhibits (2)
EX-4.2 3 ex4-2.htm EX-4.2 Exhibit 4.2 PROMISSORY NOTE $2,467,988.34 May 12, 2026 FOR VALUE RECEIVED, Foxo Technologies Inc., a Delaware corporation (the “ Maker ”) promises to pay to the order of Sabby Healthcare Master Fund, Ltd., or its registered assigns (the “ Payee ”), upon the terms set forth below, the principal sum of Two Million Four Hundred and Sixty Seven Thousand, Nine Hundred and Eighty Eight Dollars and Thirty Four Cents $2,467,988.34). (This Promissory Note, the “ Note ”). 1. Payments. (a) The principal under this Note shall be due on the earlier of: (i) May 12, 2027; or (ii) the occurrence of an Event of Default (as defined below, in each case unless due earlier in accordance with the terms of this Note 2. Unsecured Obligation. This Note is an unsecured obligation of the Company provided however the Company shall not incur any other indebtedness which is senior in preference to the Note while the Note is outstanding and provided however that repayment is made upon completion of a public offering or up-listing to a recognized stock exchange. 3. Events of Default. (a) “ Event of Default ”, wherever used herein, means any one of the following events …
Open exhibit ↗